Cetera Investment Advisers trimmed its holdings in ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 9.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 91,663 shares of the company’s stock after selling 9,329 shares during the quarter. Cetera Investment Advisers owned 0.21% of ARK Genomic Revolution ETF worth $2,232,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Private Wealth Asset Management LLC lifted its holdings in shares of ARK Genomic Revolution ETF by 70.0% in the 2nd quarter. Private Wealth Asset Management LLC now owns 1,275 shares of the company’s stock valued at $31,000 after buying an additional 525 shares during the period. Atlantic Union Bankshares Corp purchased a new position in ARK Genomic Revolution ETF during the second quarter valued at approximately $34,000. Headlands Technologies LLC acquired a new position in ARK Genomic Revolution ETF in the first quarter valued at approximately $45,000. UMB Bank n.a. purchased a new stake in ARK Genomic Revolution ETF in the 2nd quarter worth approximately $87,000. Finally, ARK Investment Management LLC boosted its position in ARK Genomic Revolution ETF by 11.0% in the 2nd quarter. ARK Investment Management LLC now owns 4,321 shares of the company’s stock worth $105,000 after purchasing an additional 429 shares in the last quarter.
ARK Genomic Revolution ETF Stock Up 32.0%
BATS:ARKG opened at $31.16 on Friday. The company has a 50 day moving average price of $29.60 and a 200-day moving average price of $26.08. ARK Genomic Revolution ETF has a 1-year low of $17.51 and a 1-year high of $31.16.
About ARK Genomic Revolution ETF
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
Read More
- Five stocks we like better than ARK Genomic Revolution ETF
- Stock Sentiment Analysis: How it Works
- Meta Platforms May Ditch NVIDIA Chips—Here’s Why Investors Care
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- SoFi Technologies: From Fintech Speculation to Profit Engine
- Why Invest in 5G? How to Invest in 5G Stocks
- Gold to $5,000? What Bank of America and UBS Have to Say
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKG – Free Report).
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.
